Delcath Systems (DCTH) had the highest return in Q1 2018 by a small-cap US stock, returning 13,927.2%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Delcath Systems (DCTH) | Q1 2018 | 13,927.24% |
BlueLinx (BXC) | Q1 2018 | 233.57% |
Geron (GERN) | Q1 2018 | 130.98% |
POET Technologies (POET) | Q1 2018 | 123.53% |
Tandem Diabetes Care (TNDM) | Q1 2018 | 111.06% |
Iovance Biotherapeutics (IOVA) | Q1 2018 | 108.64% |
Zevra Therapeutics (ZVRA) | Q1 2018 | 95.06% |
Gyre Therapeutics (GYRE) | Q1 2018 | 89.15% |
X4 Pharmaceuticals (XFOR) | Q1 2018 | 79.39% |
Vericel Corp Ord (VCEL) | Q1 2018 | 79.28% |
Nektar Therapeutics (NKTR) | Q1 2018 | 78.38% |
Eastman Kodak (KODK) | Q1 2018 | 75.41% |
Rocket Pharmaceuticals (RCKT) | Q1 2018 | 73.61% |
Novavax (NVAX) | Q1 2018 | 70.73% |
American Public Education (APEI) | Q1 2018 | 69.96% |
Syndax Pharmaceuticals (SNDX) | Q1 2018 | 62.81% |
Cerus (CERS) | Q1 2018 | 62.13% |
Larimar Therapeutics (LRMR) | Q1 2018 | 59.87% |
American Superconductor (AMSC) | Q1 2018 | 57.3% |
QuinStreet (QNST) | Q1 2018 | 52.02% |
Ameresco (AMRC) | Q1 2018 | 51.16% |
PAR Technology (PAR) | Q1 2018 | 50.7% |
Hello (MOMO) | Q1 2018 | 50.48% |
InnovAge (INNV) | Q1 2018 | 47.35% |
Enanta Pharmaceuticals (ENTA) | Q1 2018 | 46.68% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
